Eric Arzubi: The Hidden Crisis in Healthcare Ownership and Leadership
Eric Arzubi, Co-Founder Frontier Psychiatry and Assistant Clinical Professor, Yale Child Study Center, shared a post onĀ LinkedIn:
”Lawyers can own law firms. Doctors cannot own hospitals.
You read that right.
ABA Rule 5.4 has protected lawyer ownership of law firms since 1983. Non-lawyers cannot own, manage, or share profits from a law practice.
Medicine has no such protection.
Only 5 percent of U.S. hospital CEOs are physicians. In 2010, the ACA banned doctors from building new hospitals at all. Section 6001 was a backroom deal. The American Hospital Association lobbied for the ban as the price of backing the ACA.
Physicians were traded away. Private equity walked in.
Here is what happened:
- 25 percent rise in hospital acquired conditions after private equity buyouts
- 18 percent cut to emergency room staffing budgets at private equity owned hospitals
- Hospital assets dropped 24 percent within two years of private equity purchase
- Average private equity hospital star rating is 2.5 out of 5
Here is what physician leadership looks like:
- Quality scores 25 percent higher at physician led hospitals
- Charges one third lower at physician owned hospitals
- Mayo Clinic, Cleveland Clinic, Johns Hopkins are physician led for a century
Think about who suffers when the people who understand medicine do not control it:
- The nurse whose staffing ratio was cut to protect a quarterly earnings report
- The doctor who went into medicine to lead but now takes orders from an MBA who has never touched a patient
- The rural town whose hospital closed because it was not profitable enough for investors
The AMA and more than 90 medical groups now back repealing the ban. Bills to lift it sit in Congress with bipartisan support.
But 15 years of inaction raises a hard question: is lobbying without power enough
We do not have a healthcare leadership crisis. We have a healthcare ownership crisis.”

Stay updated with Hemostasis Today.
-
Jun 29, 2026, 03:10Aryabhatta Sadhu: ABO and Rh Incompatibility In Stem Cell Transplantation
-
Jun 29, 2026, 02:41Arun V. J.: ISBT Is Where the Future of Transfusion Medicine Begins
-
Jun 29, 2026, 02:41Manish Raturi: Does Patient Type Matter in Massive Blood Transfusion?
-
Jun 29, 2026, 02:25Hortense Ngegni: From Poster Presentation to Global Connections at ISBT 2026
-
Jun 29, 2026, 01:19Peter Jaworski: Grateful to Win the 2026 Plasma Hero Award at Immune Deficiency Foundation Conference
-
Jun 29, 2026, 01:11Gerrit M. Grosse: Mapping the Landscape of Biomarkers in Post-Stroke Cognitive Impairment
-
Jun 29, 2026, 01:07Katerina Pavenski: Key Insights on Patient Blood Management at ISBT 2026
-
Jun 28, 2026, 19:05Jack Shuang Hou: Novo Nordisk to Present New Haemophilia Data on Investigational Denecimig at ISTH 2026
-
Jun 28, 2026, 19:05Pinar Demirtepe: Not All “Blood Thinners” Are the Same